Dimerization of chemokine receptors and its functional consequences

Cytokine and Growth Factor Reviews

Volumn 16, Issue 6, 2005, Pages 611-623

  Springael, Jean Yves ^a   Urizar, Eneko ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Chemokines; Cooperativity; Dimerization; GPCR

Indexed keywords

4 AMINOBUTYRIC ACID; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RHODOPSIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; DNA POLYMORPHISM; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; VIRUS REPLICATION;

EID: 27144548417     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.05.005     Document Type: Article

References (154)

1. J. Bockaert, and J.P. Pin Molecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J 18 1999 1723 1729
2. P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hebert, R. Horuk, and K. Matsushima International union of pharmacology. XXII. Nomenclature for chemokine receptors Pharmacol Rev 52 2000 145 176
3. P.M. Murphy International union of pharmacology. XXX. Update on chemokine receptor nomenclature Pharmacol Rev 54 2002 227 229
4. A.E. Proudfoot Chemokine receptors: multifaceted therapeutic targets Nat Rev Immunol 2 2002 106 115
5. Z. Johnson, C.A. Power, C. Weiss, F. Rintelen, H. Ji, and T. Ruckle Chemokine inhibition - why, when, where, which and how? Biochem Soc Trans 32 2004 366 377
6. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, and B.A. Fox Crystal structure of rhodopsin: a G protein-coupled receptor Science 289 2000 739 745
7. T. Okada, M. Sugihara, A.N. Bondar, M. Elstner, P. Entel, and V. Buss The retinal conformation and its environment in rhodopsin in light of a new 2.2 angstrom crystal structure J Mol Biol 342 2004 571 583
8. T. Okada, and H. Nakamichi X-ray crystallography of rhodopsin Phase Transitions 77 2004 21 29
9. J. Li, P.C. Edwards, M. Burghammer, C. Villa, and G.F.X. Schertler Structure of bovine rhodopsin in a trigonal crystal form J Mol Biol 343 2004 1409 1438
10. G. Milligan, D. Ramsay, G. Pascal, and J.J. Carrillo GPCR dimerisation Life Sci 74 2003 181 188
11. S. Terrillon, and M. Bouvier Roles of G-protein-coupled receptor dimerization - from ontogeny to signalling regulation EMBO Rep 5 2004 30 34
12. K.M. Kroeger, and K.A. Eidne Study of G-protein-coupled receptor-protein interactions by bioluminescence resonance energy transfer Meth Mol Biol 259 2004 323 333
13. G.E. Breitwieser G protein-coupled receptor oligomerization - implications for G protein activation and cell signaling Circ Res 94 2004 17 27
14. J.L. Hansen, J. Theilade, S. Haunso, and S.P. Sheikh Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits G alpha(q) protein signaling but not ERK activation J Biol Chem 279 2004 24108 24115
15. S. Bulenger, S. Marullo, and M. Bouvier Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation Trends Pharmacol Sci 26 2005 131 137
16. M. Baggiolini Chemokines and leukocyte traffic Nature 392 1998 565 568
17. G.M. Clore, E. Appella, M. Yamada, K. Matsushima, and A.M. Gronenborn Three-dimensional structure of interleukin 8 in solution Biochemistry 29 1990 1689 1696
18. E.T. Baldwin, I.T. Weber, R. St Charles, J.C. Xuan, E. Appella, and M Yamada Crystal structure of interleukin 8: symbiosis of NMR and crystallography Proc Natl Acad Sci USA 88 1991 502 506
19. P.J. Lodi, D.S. Garrett, J. Kuszewski, M.L. Tsang, J.A. Weatherbee, and W.J. Leonard High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR Science 263 1994 1762 1767
20. C.W. Chung, R.M. Cooke, A.E. Proudfoot, and T.N. Wells The three-dimensional solution structure of RANTES Biochemistry 34 1995 9307 9314
21. 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimmer Biochemistry 35 1996 6569 6584
22. M.P. Crump, J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, and F. Arenzana-Seisdedos Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J 16 1997 6996 7007
23. W. Shao, L.F. Jerva, J. West, E. Lolis, and B.I. Schweitzer Solution structure of murine macrophage inflammatory protein-2 Biochemistry 37 1998 8303 8313
24. L.S. Mizoue, J.F. Bazan, E.C. Johnson, and T.M. Handel Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1 Biochemistry 38 1999 1402 1414
25. G.M. Clore, and A.M. Gronenborn 3-Dimensional structures of alpha-chemokines and beta-chemokines Faseb J 9 1995 57 62
26. K.S. Kim, K. Rajarathnam, I. ClarkLewis, and B.D. Sykes Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3 Febs Lett 395 1996 277 282
27. I.V. Nesmelova, Y. Sham, A.Z. Dudek, L.I. van Eijk, G. Wu, and A. Slungaard Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level J Biol Chem 280 2005 4948 4958
28. T.N. Wells, F. Guye-Coulin, and K.B. Bacon Peptides from the amino-terminus of RANTES cause chemotaxis of human T-lymphocytes Biochem Biophys Res Commun 211 1995 100 105
29. D.R. Pakianathan, E.G. Kuta, D.R. Artis, N.J. Skelton, and C.A. Hebert Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5 Biochemistry 36 1997 9642 9648
30. J.S. Laurence, C. Blanpain, A. De Leener, M. Parmentier, and P.J. LiWang Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions Biochemistry 40 2001 4990 4999
31. M.R. Mayer, and M.J. Stone Identification of receptor binding and activation determinants in the N-terminal and N-loop regions of the CC chemokine eotaxin J Biol Chem 276 2001 13911 13916
32. A. Bondue, S.C. Jao, C. Blanpain, M. Parmentier, and P.J. LiWang Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding Biochemistry 41 2002 13548 13555
33. C. Blanpain, R. Buser, C.A. Power, M. Edgerton, C. Buchanan, and M. Mack A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors J Leukoc Biol 69 2001 977 985
34. C. Blanpain, B.J. Doranz, A. Bondue, C. Govaerts, A. De Leener, and G. Vassart The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle J Biol Chem 278 2003 5179 5187
35. 2-terminal residues J Exp Med 181 1995 631 640
36. J.H. Gong, M. Uguccioni, B. Dewald, M. Baggiolini, and I. Clark-Lewis RANTES and MCP-3 antagonists bind multiple chemokine receptors J Biol Chem 271 1996 10521 10527
37. F. Arenzana-Seisdedos, J.L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, and B. Moser HIV blocked by chemokine antagonist Nature 383 1996 400
38. I. Clark-Lewis, I. Mattioli, J.H. Gong, and P. Loetscher Structure-function relationship between the human chemokine receptor CXCR3 and its ligands J Biol Chem 278 2003 289 295
39. E. Guan, J.H. Wang, and M.A. Norcross Identification of human macrophage inflammatory proteins 1 alpha and 1 beta as a native secreted heterodimer J Biol Chem 276 2001 12404 12409
40. A.J. Hoogewerf, G.S.V. Kuschert, A.E.I. Proudfoot, F. Borlat, I. ClarkLewis, and C.A. Power Glycosaminoglycans mediate cell surface oligomerization of chemokines Biochemistry 36 1997 13570 13578
41. A.E.I. Proudfoot, T.M. Handel, Z. Johnson, E.K. Lau, P. LiWang, and I. Clark-Lewis Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc Natl Acad Sci USA 100 2003 1885 1890
42. C.D. Paavola, S. Hemmerich, D. Grunberger, I. Polsky, A. Bloom, and R. Freedman Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B J Biol Chem 273 1998 33157 33165
43. H. Fernando, C. Chin, J. Rosgen, and K. Rajarathnam Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor J Biol Chem 279 2004 36175 36178
44. S. Struyf, P. Proost, J.P. Lenaerts, G. Stoops, A. Wuyts, and J. Van Damme Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine Regakine-1 Blood 97 2001 2197 2204
45. A. Krug, R. Uppaluri, F. Facchetti, B.G. Dorner, K.C.F. Sheehan, and R.D. Schreiber Cutting edge: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation J Immunol 169 2002 6079 6083
46. B. Moser, M. Wolf, A. Walz, and P. Loetscher Chemokines: multiple levels of leukocyte migration control Trends Immunol 25 2004 75 84
47. J.P. Moore, S.G. Kitchen, P. Pugach, and J.A. Zack The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection AIDS Res Hum Retroviruses 20 2004 111 126
48. U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors Endocr Rev 21 2000 90 113
49. C. Tournamille, K.C. Le Van, P. Gane, D. Blanchard, A.E. Proudfoot, and J.P. Cartron Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding J Biol Chem 272 1997 16274 16280
50. C. Blanpain, B. Lee, J. Vakili, B.J. Doranz, C. Govaerts, and I. Migeotte Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity J Biol Chem 274 1999 18902 18908
51. L.S. Ai, and F. Liao Mutating the four extracellular cysteines in the chemokine receptor CCR6 reveals their differing roles in receptor trafficking, ligand binding, and signaling Biochemistry 41 2002 8332 8341
52. M. Samson, G. LaRosa, F. Libert, P. Paindavoine, M. Detheux, and G. Vassart The second extracellular loop of CCR5 is the major determinant of ligand specificity J Biol Chem 272 1997 24934 24941
53. K.H. Han, S.R. Green, R.K. Tangirala, S. Tanaka, and O. Quehenberger Role of the first extracellular loop in the functional activation of CCR2 - the first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling J Biol Chem 274 1999 32055 32062
54. B. Lee, M. Sharron, C. Blanpain, B.J. Doranz, J. Vakili, and P. Setoh Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function J Biol Chem 274 1999 9617 9626
55. M. Farzan, T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, and N.P. Gerard Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry Cell 96 1999 667 676
56. C. Blanpain, B.J. Doranz, J. Vakili, J. Rucker, C. Govaerts, and S.S. Baik Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein J Biol Chem 274 1999 34719 34727
57. A.M. Fong, S.M. Alam, T. Imai, B. Haribabu, and D.D. Patel CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion J Biol Chem 277 2002 19418 19423
58. G.J. LaRosa, K.M. Thomas, M.E. Kaufmann, R. Mark, M. White, and L. Taylor Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity J Biol Chem 267 1992 25402 25406
59. S.J. Siciliano, T.E. Rollins, J. Demartino, Z. Konteatis, L. Malkowitz, and G. Vanriper 2-site binding of C5A by its receptor - an alternative binding paradigm for G-protein-coupled receptors Proc Natl Acad Sci USA 91 1994 1214 1218
60. F.S. Monteclaro, and I.F. Charo The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1 alpha receptor, confers chemokine selectivity - evidence for a two-step mechanism for MCP-1 receptor activation J Biol Chem 271 1996 19084 19092
61. C. Bissantz Conformational changes of G protein-coupled receptors during their activation by agonist binding J Recept Signal Transduct Res 23 2003 123 153
62. J. Gosling, F.S. Monteclaro, R.E. Atchison, H. Arai, C.L. Tsou, and M.A. Goldsmith Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity Proc Natl Acad Sci USA 94 1997 5061 5066
63. J.A. Ballesteros, A.D. Jensen, G. Liapakis, S.G. Rasmussen, L. Shi, and U. Gether Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6 J Biol Chem 276 2001 29171 29177
64. G.A. Auger, J.E. Pease, X. Shen, G. Xanthou, and M.D. Barker Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression Eur J Immunol 32 2002 1052 1058
65. B. Lagane, S. Ballet, T. Planchenault, K. Balabanian, E. Le Poul, and C. Blanpain Mutation of the DRY motif reveals different structural requirements for CCR5-mediated signaling and receptor endocytosis Mol Pharmacol 67 2005 1966 1976
66. L.S. Barak, L. Menard, S.S. Ferguson, A.M. Colapietro, and M.G. Caron The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor Biochemistry 34 1995 15407 15414
67. I. Aramori, S.S. Ferguson, P.D. Bieniasz, J. Zhang, B. Cullen, and M.G. Cullen Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor EMBO J 16 1997 4606 4616
68. O. Fritze, S. Filipek, V. Kuksa, K. Palczewski, K.P. Hofmann, and O.P. Ernst Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation Proc Natl Acad Sci USA 100 2003 2290 2295
69. L. Montanelli, J.J. Van Durme, G. Smits, M. Bonomi, P. Rodien, and E.J. Devor Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor Mol Endocrinol 18 2004 2061 2073
70. E. Urizar, S. Claeysen, X. Deupi, C. Govaerts, S. Costagliola, and G. Vassart An activation switch in the rhodopsin family of G protein coupled receptors: the thyrotropin receptor J Biol Chem 2005 17135 17141
71. C. Govaerts, C. Blanpain, X. Deupi, S. Ballet, J.A. Ballesteros, and S.J. Wodak The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation J Biol Chem 276 2001 13217 13225
72. D.L. Farrens, C. Altenbach, K. Yang, W.L. Hubbell, and H.G. Khorana Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin Science 274 1996 768 770
73. P. Ghanouni, J.J. Steenhuis, D.L. Farrens, and B.K. Kobilka Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor Proc Natl Acad Sci USA 98 2001 5997 6002
74. U. Gether, S. Lin, P. Ghanouni, J.A. Ballesteros, H. Weinstein, and B.K. Kobilka Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor EMBO J 16 1997 6737 6747
75. K. Cai, J. Klein-Seetharaman, J. Hwa, W.L. Hubbell, and H.G. Khorana Structure and function in rhodopsin: effects of disulfide cross-links in the cytoplasmic face of rhodopsin on transducin activation and phosphorylation by rhodopsin kinase Biochemistry 38 1999 12893 12898
76. A.M. Spiegel Defects in G protein-coupled signal transduction in human disease Annu Rev Physiol 58 1996 143 170
77. G.B. Cohen, T. Yang, P.R. Robinson, and D.D. Oprian Constitutive activation of opsin: influence of charge at position 134 and size at position 296 Biochemistry 32 1993 6111 6115
78. A. Scheer, F. Fanelli, T. Costa, P.G. De Benedetti, and S. Cotecchia Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation EMBO J 15 1996 3566 3578
79. J.M. Kim, C. Altenbach, R.L. Thurmond, H.G. Khorana, and W.L. Hubbell Structure and function in rhodopsin: rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state Proc Natl Acad Sci USA 94 1997 14273 14278
80. S.G. Rasmussen, A.D. Jensen, G. Liapakis, P. Ghanouni, J.A. Javitch, and U. Gether Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6 Mol Pharmacol 56 1999 175 184
81. N. Zhou, Z. Luo, J. Luo, D. Liu, J.W. Hall, and R.J. Pomerantz Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies J Biol Chem 276 2001 42826 42833
82. M.G. Paterlini Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity Biophys J 83 2002 3012 3031
83. T.A. Berkhout, F.E. Blaney, A.M. Bridges, D.G. Cooper, I.T. Forbes, and A.D. Gribble CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach J Med Chem 46 2003 4070 4086
84. L.A. Castonguay, Y.M. Weng, W. Adolfsen, J. Di Salvo, R. Kilburn, and C.G. Caldwell Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study the binding pocket Biochemistry 42 2003 1544 1550
85. C. Govaerts, A. Bondue, J.Y. Springael, M. Olivella, X. Deupi, and E. Le Poul Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3 J Biol Chem 278 2003 1892 1903
86. D.A. Arias, J.M. Navenot, W.B. Zhang, J. Broach, and S.C. Peiper Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2 J Biol Chem 278 2003 36513 36521
87. T.E. Hebert, S. Moffett, J.P. Morello, T.P. Loisel, D.G. Bichet, and C. Barret A peptide derived from a beta(2)-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation J Biol Chem 271 1996 16384 16392
88. S. Cvejic, and L.A. Devi Dimerization of the delta opioid receptor: implication for a role in receptor internalization J Biol Chem 272 1997 26959 26964
89. F.Y. Zeng, and J. Wess Identification and molecular characterization of m3 muscarinic receptor dimers J Biol Chem 274 1999 19487 19497
90. P. van Roessel, and A.H. Brand Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins Nat Cell Biol 4 2002 E15 E20
91. S. Angers, A. Salahpour, and M. Bouvier Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function Annu Rev Pharmacol Toxicol 42 2002 409 435
92. M. Bai Dimerization of G-protein-coupled receptors: roles in signal transduction Cell Signal 16 2004 175 186
93. P.R. Gouldson, C.R. Snell, R.P. Bywater, C. Higgs, and C.A. Reynolds Domain swapping in G-protein coupled receptor dimers Protein Eng 11 1998 1181 1193
94. M.K. Dean, C. Higgs, R.E. Smith, R.P. Bywater, C.R. Snell, and P.D. Scott Dimerization of G-protein-coupled receptors J Med Chem 44 2001 4595 4614
95. Y. Liang, D. Fotiadis, S. Filipek, D.A. Saperstein, K. Palczewski, and A. Engel Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes J Biol Chem 278 2003 21655 21662
96. R. Maggio, Z. Vogel, and J. Wess Reconstitution of functional muscarinic receptors by coexpression of amino-terminal and carboxyl-terminal receptor fragments Febs Lett 319 1993 195 200
97. C. Monnot, C. Bihoreau, S. Conchon, K.M. Curnow, P. Corvol, and E. Clauser Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling - reconstitution of the binding site by co-expression of two deficient mutants J Biol Chem 271 1996 1507 1513
98. A. Schulz, R. Grosse, G. Schultz, T. Gudermann, and T. Schoneberg Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors J Biol Chem 275 2000 2381 2389
99. D. Mesnier, and J.L. Baneres Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B(4) receptor BLT1 J Biol Chem 279 2004 49664 49670
100. M. Benkirane, D.Y. Jin, R.F. Chun, R.A. Koup, and K.T. Jeang Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32 J Biol Chem 272 1997 30603 30606
101. M. Mellado, J.M. Rodriguez-Frade, A.J. Vila-Coro, S. Fernandez, dA. Martin, and D.R. Jones Chemokine receptor homo- or heterodimerization activates distinct signaling pathways EMBO J 20 2001 2497 2507
102. H. Issafras, S. Angers, S. Bulenger, C. Blanpain, M. Parmentier, and C. Labbe-Jullie Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors J Biol Chem 277 2002 34666 34673
103. P. Hernanz-Falcon, J.M. Rodriguez-Frade, A. Serrano, D. Juan, A. del Sol, and S.F. Soriano Identification of amino acid residues crucial for chemokine receptor dimerization Nat Immunol 5 2004 216 223
104. L. El Asmar, J.Y. Springael, S. Ballet, E.U. Andrieu, G. Vassart, and M. Parmentier Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers Mol Pharmacol 67 2005 460 469
105. Y. Percherancier, Y.A. Berchiche, I. Slight, R. Volkmer-Engert, H. Tamamura, and N. Fujii Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers J Biol Chem 280 2005 9895 9903
106. M. Mellado, J.M. Rodriguez-Frade, A.J. Vila-Coro, A.M. de Ana, and C. Martinez Chemokine control of HIV-1 infection Nature 400 1999 723 724
107. J.M. Rodriguez-Frade, A.J. Vila-Coro, A.M. de Ana, J.P. Albar, A. Martinez, and M. Mellado The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2 Proc Natl Acad Sci USA 96 1999 3628 3633
108. A.J. Vila-Coro, M. Mellado, dA Martin, P. Lucas, G. del Real, and A. Martinez HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization Proc Natl Acad Sci USA 97 2000 3388 3393
109. G.J. Babcock, M. Farzan, and J. Sodroski Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor J Biol Chem 278 2003 3378 3385
110. F. Trettel, S. Di Bartolomeo, C. Lauro, M. Catalano, M.T. Ciotti, and C. Limatola Ligand-independent CXCR2 dimerization J Biol Chem 278 2003 40980 40988
111. C. Limatola, S. Di Bartolomeo, F. Trettel, C. Lauro, M.T. Ciotti, and D. Mercanti Expression of AMPA-type glutamate receptors in HEK cells and cerebellar granule neurons impairs CXCL2-mediated chemotaxis J Neuroimmunol 134 2003 61 71
112. C. Chen, J. Li, G. Bot, I. Szabo, T.J. Rogers, and L.Y. Liu-Chen Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor Eur J Pharmacol 483 2004 175 186
113. P.T. Toth, D.J. Ren, and R.J. Miller Regulation of CXCR4 receptor dimerization by the chemokine SDF-1 alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study J Pharmacol Exp Ther 310 2004 8 17
114. S. Suzuki, L.F. Chuang, P. Yau, R.H. Doi, and R.Y. Chuang Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells Exp Cell Res 280 2002 192 200
115. K.A. Jones, B. Borowsky, J.A. Tamm, D.A. Craig, M.M. Durkin, and M. Dai GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2 Nature 396 1998 674 679
116. K. Kaupmann, B. Malitschek, V. Schuler, J. Heid, W. Froestl, and P. Beck GABA(B)-receptor subtypes assemble into functional heteromeric complexes Nature 396 1998 683 687
117. J.H. White, A. Wise, M.J. Main, A. Green, N.J. Fraser, and G.H. Disney Heterodimerization is required for the formation of a functional GABA(B) receptor Nature 396 1998 679 682
118. R. Kuner, G. Kohr, S. Grunewald, G. Eisenhardt, A. Bach, and H.C. Kornau Role of heteromer formation in GABAB receptor function Science 283 1999 74 77
119. J.P. Pin, T. Galvez, and L. Prezeau Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors Pharmacol Ther 98 2003 325 354
120. G. Nelson, M.A. Hoon, J. Chandrashekar, Y.F. Zhang, N.J.P. Ryba, and C.S. Zuker Mammalian sweet taste receptors Cell 106 2001 381 390
121. G. Nelson, J. Chandrashekar, M.A. Hoon, L.X. Feng, G. Zhao, and NJ.P. Ryba An amino-acid taste receptor Nature 416 2002 199 202
122. B.A. Jordan, and L.A. Devi G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 1999 697 700
123. K. Yoshioka, O. Saitoh, and H. Nakata Heteromeric association creates a P2Y-like adenosine receptor Proc Natl Acad Sci USA 98 2001 7617 7622
124. J. Kniazeff, A.S. Bessis, D. Maurel, H. Ansanay, L. Prezeau, and J.P. Pin Closed state of both binding domains of homodimeric mGlu receptors is required for full activity Nat Struct Mol Biol 11 2004 706 713
125. Novi F, Stanasila L, Giorgi F, Corsini GU, Cotecchia S, Maggio R. Paired activation of the two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane. J Biol Chem 2005; Epub ahead of print.
126. J.L. Baneres, and J. Parello Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B-4 receptor BLT1 and the G-protein J Mol Biol 329 2003 815 829
127. S. Filipek, K.A. Krzysko, D. Fotiadis, Y. Liang, D.A. Saperstein, and A. Engel A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface Photochem Photobiol Sci 3 2004 628 638
128. J.J. Carrillo, J. Pediani, and G. Milligan Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins J Biol Chem 278 2003 42578 42587
129. E. Urizar, L. Montanelli, T. Loy, M. Bonomi, S. Swillens, and C. Gales Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity EMBO J 24 2005 1954 1964
130. V. Hlavackova, C. Goudet, J. Kniazeff, A. Zikova, D. Maurel, and C. Vol Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR EMBO J 24 2005 499 509
131. S. AbdAlla, H. Lother, A. Langer, Y. el Faramawy, and U. Quitterer Factor XIIIA transglutaminase crosslinks AT(1) receptor dimers of monocytes at the onset of atherosclerosis Cell 119 2004 343 354
132. M. Samson, F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, and C.M. Farber Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 1996 722 725
133. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, and R. Horuk Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367 377
134. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, and R. Allikmets Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco city cohort, ALIVE study Science 273 1996 1856 1862
135. M.W. Smith, M. Dean, M. Carrington, C. Winkler, G.A. Huttley, and D.A. Lomb Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia growth and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter hemophilia cohort study (MHCS), San Francisco city cohort (SFCC), ALIVE study Science 277 1997 959 965
136. N.L. Michael, L.G. Louie, A.L. Rohrbaugh, K.A. Schultz, D.E. Dayhoff, and C.E. Wang The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression Nat Med 3 1997 1160 1162
137. W.A. Paxton, R. Liu, S. Kang, L.J. Wu, T.R. Gingeras, and N.R. Landau Reduced HIV-1 infectability of CD4(+) lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines Virology 244 1998 66 73
138. S. Venkatesan, A. Petrovic, D.I. Van Ryk, M. Locati, D. Weissman, and P.M. Murphy Reduced cell surface expression of CCR5 in CCR5 Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration J Biol Chem 277 2002 2287 2301
139. R. Mariani, S. Wong, L.C.F. Mulder, D.A. Wilkinson, A.L. Reinhart, and G. LaRosa CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function J Virol 73 1999 2450 2459
140. J.M. Rodriguez-Frade, G. del Real, A. Serrano, P. Hernanz-Falcon, S.F. Soriano, and A.J. Vila-Coro Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor EMBO J 23 2004 66 76
141. M.P. Martin, M. Dean, M.W. Smith, C. Winkler, B. Gerrard, and N.L. Michael Genetic acceleration of AIDS progression by a promoter variant of CCR5 Science 282 1998 1907 1911
142. E. Gonzalez, M. Bamshad, N. Sato, S. Mummidi, R. Dhanda, and G. Catano Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes Proc Natl Acad Sci USA 96 1999 12004 12009
143. J.J. Martinson, L. Hong, R. Karanicolas, J.P. Moore, and L.G. Kostrikis Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype Aids 14 2000 483 489
144. C.A. Winkler, H. Hendel, M. Carrington, M.W. Smith, G.W. Nelson, and S.J. O'Brien Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression Jaids - J Acquir Immune Deficiency Syndromes 37 2004 1534 1538
145. M.C. Overton, S.L. Chinault, and K.J. Blumer Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor J Biol Chem 278 2003 49369 49377
146. J.J. Carrillo, J.F. Lopez-Gimenez, and G. Milligan Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor Mol Pharmacol 66 2004 1123 1137
147. P.R. Gouldson, C. Higgs, R.E. Smith, M.K. Dean, G.V. Gkoutos, and C.A. Reynolds Dimerization and domain swapping in G-protein-coupled receptors: a computational study Neuropsychopharmacology 23 2000 S60 S77
148. D. Fotiadis, Y. Liang, S. Filipek, D.A. Saperstein, A. Engel, and K. Palczewski Atomic-force microscopy: rhodopsin dimers in native disc membranes Nature 421 2003 127 128
149. D. Fotiadis, Y. Liang, S. Filipek, D.A. Saperstein, A. Engel, and K. Palczewski The G protein-coupled receptor rhodopsin in the native membrane Febs Lett 564 2004 281 288
150. J.J. Ruprecht, T. Mielke, R. Vogel, C. Villa, and G.F.X. Schertler Electron crystallography reveals the structure of metarhodopsin I EMBO J 23 2004 3609 3620
151. M. Margeta-Mitrovic, Y.N. Jan, and L.Y. Jan A trafficking checkpoint controls GABA(B) receptor heterodimerization Neuron 27 2000 97 106
152. N. Kunishima, Y. Shimada, Y. Tsuji, T. Sato, M. Yamamoto, and T. Kumasaka Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor Nature 407 2000 971 977
153. K. Ray, and B.C. Hauschild Cys-140 is critical for metabotropic glutamate receptor-1 dimerization J Biol Chem 275 2000 34245 34251
154. J. Lemay, S. Marullo, R. Jockers, M. Alizon, and A. Brelot On the dimerization of CCR5 Nat Immunol 6 2005 535 536